Envista Holdings Corp. (NVST)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Envista Holdings Corp. (NVST) trades at $27.51 with AI Score 86/100 (Grade A+). Envista Holdings Corp. is a global manufacturer and marketer of dental products and technologies. Market cap: $4.48B, Sector: Healthcare.
Price live · AI analysis from May 6, 2026NVST stock analysis for 2026: Analysts have set a consensus price target of $26.64 for Envista Holdings Corp., suggesting 3.2% downside from the current price of $27.51. The AI MoonshotScore is 86/100, indicating a strong bullish outlook. Key factors: analyst coverage, AI-driven quantitative scoring.
NVST: 7/7 perspectives are bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →Envista Holdings Corp. (NVST) Healthcare & Pipeline Overview
Envista Holdings Corp. provides dental solutions, encompassing specialty products, technologies, and equipment. Operating through two segments, the company caters to dental professionals globally with a focus on diagnosing, treating, and preventing dental conditions. With a market cap of $4.48B, Envista competes in the broader medical equipment and services sector.
What Is the Investment Thesis for NVST?
Envista Holdings Corp. presents a notable research candidate within the dental equipment and supplies market. With a market capitalization of $4.48B and a P/E ratio of 58.2, the company demonstrates significant market presence. A key value driver is its diversified product portfolio across both Specialty Products & Technologies and Equipment & Consumables segments, providing revenue stability. Growth catalysts include expansion in emerging markets and continued innovation in digital dentistry solutions. The company's ongoing focus on research and development is expected to drive new product launches and maintain its competitive edge. However, potential risks include fluctuations in dental procedure volumes and increasing competition from established and emerging players. The company's beta of 0.98 indicates moderate volatility relative to the market.
Based on FMP financials and quantitative analysis
NVST Key Highlights
- Market Cap of $4.48B indicates a strong market presence within the dental equipment and supplies industry.
- P/E ratio of 58.2 reflects investor expectations of future earnings growth, although it is relatively high compared to industry peers.
- Gross Margin of 55.1% demonstrates efficient cost management and pricing power in its product offerings.
- Profit Margin of 2.4% indicates room for improvement in operational efficiency and expense management.
- Beta of 0.98 suggests the stock's volatility is slightly less than the overall market, providing some stability for investors.
Who Are NVST's Competitors?
NVST is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| APGE Apogee Therapeutics, Inc. | $133.50 | +0.44% | $8.24B | 71 |
| ALHC Alignment Healthcare, Inc. | $24.56 | +3.19% | $5.08B | 96 |
| PRVA Privia Health Group, Inc. | $27.27 | -0.35% | $3.44B | 89 |
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| FEDDX Fidelity Emerging Markets Discovery Fd | $22.90 | +0.62% | $1.51B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NVST's Key Strengths?
- Comprehensive product portfolio covering various dental specialties.
- Strong brand recognition and reputation in the dental industry.
- Global presence with established distribution channels.
- Focus on innovation and digital dentistry solutions.
What Are NVST's Weaknesses?
- Profit margin of 2.4% indicates potential inefficiencies.
- High P/E ratio of 58.2 suggests potential overvaluation.
- Dependence on dental procedure volumes, which can be affected by economic conditions.
- Exposure to regulatory changes and compliance requirements.
What Could Drive NVST Stock Higher?
- New product launches in digital dentistry solutions expected in Q3 2026.
- Expansion of distribution network in emerging markets.
- Continued investment in research and development to drive innovation.
- Strategic acquisitions to expand product portfolio and market reach.
What Are the Key Risks for NVST?
- Rich valuation — a P/E of 58.2 runs well above the Healthcare sector’s ~23x, leaving little room for a miss.
- Fluctuations in dental procedure volumes due to economic conditions.
- Intense competition from established and emerging players.
- Changes in reimbursement policies and healthcare regulations.
- Patent expirations and generic competition.
- Supply chain disruptions affecting manufacturing and distribution.
What Are the Growth Opportunities for NVST?
- Expansion in Emerging Markets: Envista has a significant opportunity to expand its presence in emerging markets, where dental care awareness and access are increasing. These markets, particularly in Asia-Pacific and Latin America, represent a substantial growth potential as disposable incomes rise and healthcare infrastructure improves. By tailoring its product offerings and distribution strategies to meet the specific needs of these markets, Envista can capture a larger share of the global dental market. This expansion could contribute significantly to revenue growth over the next 3-5 years.
- Innovation in Digital Dentistry: The dental industry is undergoing a digital transformation, with increasing adoption of technologies such as digital imaging, CAD/CAM systems, and 3D printing. Envista can capitalize on this trend by investing in research and development to create innovative digital dentistry solutions that improve the efficiency, accuracy, and patient experience of dental procedures. This includes developing advanced software, imaging systems, and materials that integrate seamlessly into dental practices. The market for digital dentistry is projected to grow significantly over the next decade, providing a substantial opportunity for Envista.
- Strategic Acquisitions: Envista can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. By acquiring companies with complementary products or technologies, Envista can strengthen its competitive position and accelerate its growth. Potential acquisition targets include companies specializing in niche dental products, emerging technologies, or geographic markets where Envista has limited presence. These acquisitions can provide access to new customers, distribution channels, and intellectual property, enhancing Envista's long-term growth prospects.
- Development of Advanced Materials: The demand for advanced dental materials, such as biocompatible implants, high-strength ceramics, and aesthetic restorative materials, is increasing. Envista can invest in research and development to create innovative materials that offer superior performance, durability, and aesthetics. These materials can be used in a wide range of dental applications, including implants, crowns, bridges, and veneers. By developing and marketing advanced materials, Envista can differentiate itself from competitors and capture a larger share of the dental materials market. The market for advanced dental materials is expected to grow steadily over the next several years.
- Enhancing Customer Education and Training: Providing comprehensive education and training programs for dental professionals is crucial for driving adoption of Envista's products and technologies. Envista can invest in developing online and in-person training programs that educate dentists and dental staff on the proper use and benefits of its products. These programs can cover a wide range of topics, including implant placement, orthodontic treatment, digital dentistry workflows, and infection control protocols. By enhancing customer education and training, Envista can build stronger relationships with dental professionals and increase product sales. The investment in education and training will pay dividends in the form of increased customer loyalty and product adoption.
What Opportunities Does NVST Have?
- Expansion in emerging markets with growing dental care demand.
- Increasing adoption of digital dentistry technologies.
- Strategic acquisitions to expand product offerings and market reach.
- Development of advanced dental materials and solutions.
What Threats Does NVST Face?
- Intense competition from established and emerging players.
- Fluctuations in dental procedure volumes due to economic factors.
- Patent expirations and generic competition.
- Changes in reimbursement policies and healthcare regulations.
What Are NVST's Competitive Advantages?
- Diversified product portfolio across multiple dental segments.
- Established brand reputation and customer relationships.
- Strong research and development capabilities.
- Global distribution network.
What Does NVST Do?
Envista Holdings Corp. is a global manufacturer and marketer of dental products and technologies, dedicated to helping dental professionals improve patients' lives. Spun off from Danaher Corporation in 2019, Envista has quickly established itself as a significant player in the dental industry. Headquartered in Brea, California, the company employs approximately 12,300 individuals. Envista operates through two primary segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment focuses on developing, manufacturing, and marketing dental implant systems, prosthetics, associated treatment software, orthodontic bracket systems, aligners, and lab products. This segment caters to specialized dental procedures and advanced treatment modalities. The Equipment & Consumables segment develops, manufactures, and markets a wide range of dental equipment and supplies used in dental offices. This includes digital imaging systems, software, visualization and magnification systems, treatment units, endodontic systems, restorative materials, instruments, rotary burs, impression materials, bonding agents, cements, and infection prevention products. Envista's comprehensive product portfolio allows it to serve a broad spectrum of dental professionals and address diverse patient needs, solidifying its position in the competitive dental market.
What Products and Services Does NVST Offer?
- Manufactures and markets dental implant systems.
- Provides dental prosthetics and associated treatment software.
- Offers orthodontic bracket systems and aligners.
- Develops and markets lab products for dental applications.
- Manufactures digital imaging systems and software.
- Provides treatment units and other dental practice equipment.
- Offers endodontic systems and related consumables.
- Supplies restorative materials, instruments, and infection prevention products.
How Does NVST Make Money?
- Develops and manufactures a wide range of dental products.
- Markets and sells products directly to dental professionals and through distributors.
- Generates revenue through the sale of dental equipment, consumables, and specialty products.
- Provides training and support services to customers.
What Industry Does NVST Operate In?
Envista Holdings Corp. operates in the global dental equipment and supplies market, which is characterized by steady growth driven by an aging population, increasing awareness of oral hygiene, and technological advancements in dental procedures. The market is competitive, with established players and emerging companies vying for market share. Trends include the adoption of digital dentistry solutions, such as CAD/CAM systems and 3D printing, as well as the growing popularity of cosmetic dentistry. Envista's focus on innovation and its diversified product portfolio position it well to capitalize on these trends and maintain its competitive edge. Competitors include companies offering similar dental equipment, consumables, and specialty products.
Who Are NVST's Key Customers?
- Dental professionals, including dentists, orthodontists, and oral surgeons.
- Dental laboratories.
- Hospitals and clinics.
- Dental distributors.
ROE 2%Key Financial Metrics
Return on equity for Envista Holdings Corp. stands at 2.2%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 1.2%, showing how much profit it generates from its asset base. NVST trades at a trailing price-to-earnings ratio of 58.25, above the Healthcare sector average of ~23x. Its free cash flow yield is 5.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.44 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 1.5%, the inverse of the P/E and a quick read on earnings relative to price.
Envista Holdings Corp. (NVST) Valuation Context
Valued at $4.48B, NVST is classified as a mid-cap stock. Relative to its peer group, NVST's quantitative score of 86/100 is above the peer average of 70/100.
Company Profile
Envista Holdings Corp. operates in the Medical - Equipment & Services industry within the Healthcare sector. It is headquartered in Brea, US. The company is led by CEO Paul A. Keel. NVST has traded publicly since 2019.
F-Score 8/9Financial Health
Envista Holdings Corp.'s Piotroski F-Score is 8/9, a 9-point checklist of profitability, leverage and efficiency — signaling solid underlying fundamentals. Its Altman Z-Score of 1.86 places it in the grey zone, a middle ground that warrants monitoring.
FY2026 estForward Outlook
Wall Street analysts project Envista Holdings Corp. revenue of about $2.86B for fiscal 2026, with EPS near $1.43. The estimate reflects 11 contributing analysts.
Net buyingInsider Activity
Over the past six months, Envista Holdings Corp. insiders filed 30 SEC Form 4 transactions — 7 sales and 23 purchases. On net that is roughly 313K shares acquired (about $2.8M) — insiders putting money in tends to read as conviction.
NVST Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Comprehensive product portfolio covering various dental specialties.
- Strong brand recognition and reputation in the dental industry.
- Global presence with established distribution channels.
- Focus on innovation and digital dentistry solutions.
Bear Case
- Profit margin of 2.4% indicates potential inefficiencies.
- High P/E ratio of 58.2 suggests potential overvaluation.
- Dependence on dental procedure volumes, which can be affected by economic conditions.
- Exposure to regulatory changes and compliance requirements.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
NVST Latest News
-
Barclays Maintains Overweight on Envista Holdings, Lowers Price Target to $32
benzinga · Jun 11, 2026
-
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
zacks.com · Jun 8, 2026
-
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
zacks.com · Jun 5, 2026
-
3 Stocks Under $50 That Concern Us
Yahoo! Finance: NVST News · Jun 4, 2026
NVST Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NVST.
Price Targets
Consensus target: $26.64
NVST MoonshotScore
What does this score mean?
The MoonshotScore rates NVST's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Barclays Maintains Overweight on Envista Holdings, Lowers Price Target to $32
Here's Why You Should Retain NVST Stock in Your Portfolio for Now
Why Is Envista (NVST) Down 5.9% Since Last Earnings Report?
3 Stocks Under $50 That Concern Us
Leadership: Paul A. Keel
CEO
Paul A. Keel serves as the Chief Executive Officer of Envista Holdings Corporation. Prior to joining Envista, Keel held various leadership positions at Danaher Corporation, Envista's former parent company. His experience includes roles in strategic planning, business development, and operations across multiple Danaher businesses. Keel's background encompasses a strong understanding of the dental industry and a proven track record of driving growth and innovation. He brings extensive experience in leading global organizations and executing strategic initiatives.
Track Record: Under Paul Keel's leadership, Envista Holdings Corp. has focused on expanding its digital dentistry solutions and strengthening its market position. Key achievements include the successful integration of acquired businesses and the launch of innovative products. Keel has emphasized operational efficiency and customer satisfaction, driving improvements in key performance indicators. His strategic decisions have contributed to Envista's growth and profitability in a competitive market.
What Investors Ask About Envista Holdings Corp. (NVST) — Healthcare
What does Envista Holdings Corp do?
Envista Holdings Corp. is a global manufacturer and marketer of dental products and technologies. The company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment focuses on dental implant systems, prosthetics, and orthodontic solutions. The Equipment & Consumables segment provides dental equipment and supplies used in dental offices. Envista's comprehensive product portfolio serves dental professionals worldwide, supporting the diagnosis, treatment, and prevention of dental conditions.
What do analysts say about NVST stock?
Analyst consensus on NVST stock is mixed, reflecting the company's growth potential and inherent risks. Key valuation metrics, such as the P/E ratio of 58.2, suggest that the stock may be trading at a premium. Growth considerations include the company's expansion in emerging markets and its focus on digital dentistry solutions. Analysts also consider the competitive landscape and potential fluctuations in dental procedure volumes. Investors should conduct their own due diligence and consider their individual risk tolerance before making investment decisions.
What are the main risks for NVST?
The main risks for Envista Holdings Corp. include fluctuations in dental procedure volumes, which can be affected by economic conditions and consumer spending. Intense competition from established and emerging players in the dental equipment and supplies market poses a threat to market share. Changes in reimbursement policies and healthcare regulations can impact the demand for dental products. Patent expirations and generic competition can erode pricing power. Supply chain disruptions can affect manufacturing and distribution, impacting revenue and profitability.
How does Envista Holdings Corp navigate regulatory approval processes?
Envista Holdings Corp. operates in a highly regulated industry, requiring adherence to stringent regulatory approval processes for its dental products and technologies. The company works closely with regulatory agencies such as the FDA in the United States and EMA in Europe to ensure compliance with applicable standards. Envista maintains a dedicated regulatory affairs team responsible for managing product approvals, post-market surveillance, and compliance monitoring. The company's track record demonstrates a commitment to regulatory compliance and patient safety.
How does Envista Holdings Corp manage patent expiration risks?
Envista Holdings Corp. faces patent expiration risks for certain products within its portfolio, which could lead to increased competition from generic alternatives. To mitigate this risk, Envista invests in research and development to create innovative products with patent protection. The company also employs lifecycle management strategies, such as developing new formulations, delivery systems, or indications for existing products. Additionally, Envista actively monitors the competitive landscape and pursues legal action to protect its intellectual property rights.
What are the key factors to evaluate for NVST?
Envista Holdings Corp. (NVST) holds an AI score of 86/100 (high). P/E: 58.2x vs the S&P 500's ~20-25x. Analysts target $26.64 (-3%). Not financial advice.
How frequently does NVST data refresh on this page?
NVST prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven NVST's recent stock price performance?
Envista Holdings Corp. (NVST) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive product portfolio covering various dental specialties. See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.